Trial Outcomes & Findings for Toronto Thromboprophylaxis Patient Safety Initiative (NCT NCT01869075)
NCT ID: NCT01869075
Last Updated: 2014-09-23
Results Overview
Rates of appropriate VTE prophylaxis were determined as the number of patients who received VTE prophylaxis as a proportion of the number of patient at risk. Rates reported are for the active phases (phase 1 and phase 2) and compare intervention to control. Appropriate VTE prophylaxis was defined as: in "Hip Fracture Surgery" - evidence-based VTE prophylaxis ordered within 24 of admission, restarted within 24 hours after surgery and continued for at least 10 days post-discharge in "Major General Surgery" - evidence-based VTE prophylaxis ordered within 24 hours post-surgery and continued for the duration of hospital stay in "Acute Medical Illness" - evidence-based VTE prophylaxis ordered within 24 hours of admission and continued for the duration of hospital stay. Evidence-based VTE prophylaxis was determined to be according to the American College of Chest Physicians (ACCP) guidelines. The 9th version was the most current version at the time of the study.
COMPLETED
NA
1895 participants
End of study (end of phase 2) - measured over duration of hospital stay.
2014-09-23
Participant Flow
Recruitment of study sites not individual patients.
After site enrolment, baseline data was collected for all sites in order to establish sample size for phases 1 and 2.
Participant milestones
| Measure |
AMI - Knowledge Translation Toolkit
AMI - Knowledge Translation (KT) toolkit includes use of pre-printed orders, audit and feedback, pharmacist as a reminder and education of staff
Knowledge Translation (KT) toolkit: KT toolkit consists of: use of pre-printed orders, use of pharmacist as project lead and human reminder for prescribing, audit and feedback, education for staff
|
AMI - Usual Care
Usual care provided at the hospital
|
MGS - Knowledge Translation Toolkit
Knowledge Translation toolkit involves use of pre-printed orders, audit and feedback, pharmacist as reminder and education of staff
Knowledge Translation (KT) toolkit: KT toolkit consists of: use of pre-printed orders, use of pharmacist as project lead and human reminder for prescribing, audit and feedback, education for staff
|
MGS - Usual Care
Usual care provided at the hospital
|
HFS - Knowledge Translation Toolkit
Knowledge Translation Toolkit consists of pre-printed orders, audit and feedback, pharmacist as a reminder and education of staff
Knowledge Translation (KT) toolkit: KT toolkit consists of: use of pre-printed orders, use of pharmacist as project lead and human reminder for prescribing, audit and feedback, education for staff
|
HFS - Usual Care
Usual care provided at the hospital
|
|---|---|---|---|---|---|---|
|
Phase 0 (Baseline)
STARTED
|
0
|
418
|
0
|
416
|
0
|
341
|
|
Phase 0 (Baseline)
COMPLETED
|
0
|
418
|
0
|
416
|
0
|
341
|
|
Phase 0 (Baseline)
NOT COMPLETED
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Phase 1
STARTED
|
45
|
75
|
45
|
75
|
30
|
90
|
|
Phase 1
COMPLETED
|
45
|
75
|
45
|
75
|
30
|
90
|
|
Phase 1
NOT COMPLETED
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Phase 2
STARTED
|
90
|
30
|
75
|
45
|
75
|
45
|
|
Phase 2
COMPLETED
|
90
|
30
|
75
|
45
|
75
|
45
|
|
Phase 2
NOT COMPLETED
|
0
|
0
|
0
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Toronto Thromboprophylaxis Patient Safety Initiative
Baseline characteristics by cohort
| Measure |
AMI - Knowledge Translation Toolkit
AMI - Knowledge Translation (KT) toolkit includes use of pre-printed orders, audit and feedback, pharmacist as a reminder and education of staff
Knowledge Translation (KT) toolkit: KT toolkit consists of: use of pre-printed orders, use of pharmacist as project lead and human reminder for prescribing, audit and feedback, education for staff
|
AMI - Usual Care
n=341 Participants
Usual care as provided at the hospital.
|
MGS - Knowledge Translation Toolkit
Knowledge Translation toolkit involves use of pre-printed orders, audit and feedback, pharmacist as reminder and education of staff
Knowledge Translation (KT) toolkit: KT toolkit consists of: use of pre-printed orders, use of pharmacist as project lead and human reminder for prescribing, audit and feedback, education for staff
|
MGS - Usual Care
n=416 Participants
Usual Care as provided at the hospital.
|
HFS - Knowledge Translation Toolkit
Knowledge Translation Toolkit consists of pre-printed orders, audit and feedback, pharmacist as a reminder and education of staff
Knowledge Translation (KT) toolkit: KT toolkit consists of: use of pre-printed orders, use of pharmacist as project lead and human reminder for prescribing, audit and feedback, education for staff
|
HFS - Usual Care
n=418 Participants
Usual Care as provided at the hospital.
|
Total
n=1175 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|---|
|
Age, Customized
18 years and older
|
—
|
341 participants
n=107 Participants
|
—
|
416 participants
n=7 Participants
|
—
|
418 participants
n=30 Participants
|
1175 participants
n=3 Participants
|
|
Sex: Female, Male
Female
|
—
|
NA Participants
n=107 Participants
|
—
|
NA Participants
n=7 Participants
|
—
|
NA Participants
n=30 Participants
|
NA Participants
n=3 Participants
|
|
Sex: Female, Male
Male
|
—
|
NA Participants
n=107 Participants
|
—
|
NA Participants
n=7 Participants
|
—
|
NA Participants
n=30 Participants
|
NA Participants
n=3 Participants
|
PRIMARY outcome
Timeframe: End of study (end of phase 2) - measured over duration of hospital stay.Population: The number of participants in the analysis was 720. In phase 1, there were 360 patients included and in phase 2, an additional 360 patients were included. The outcomes by end of study (end of phase 2) are reported. The patients in control (usual care) and intervention (Knowledge Translation toolkit) were compared.
Rates of appropriate VTE prophylaxis were determined as the number of patients who received VTE prophylaxis as a proportion of the number of patient at risk. Rates reported are for the active phases (phase 1 and phase 2) and compare intervention to control. Appropriate VTE prophylaxis was defined as: in "Hip Fracture Surgery" - evidence-based VTE prophylaxis ordered within 24 of admission, restarted within 24 hours after surgery and continued for at least 10 days post-discharge in "Major General Surgery" - evidence-based VTE prophylaxis ordered within 24 hours post-surgery and continued for the duration of hospital stay in "Acute Medical Illness" - evidence-based VTE prophylaxis ordered within 24 hours of admission and continued for the duration of hospital stay. Evidence-based VTE prophylaxis was determined to be according to the American College of Chest Physicians (ACCP) guidelines. The 9th version was the most current version at the time of the study.
Outcome measures
| Measure |
AMI - Knowledge Translation Toolkit
n=135 Participants
AMI - Knowledge Translation (KT) toolkit includes use of pre-printed orders, audit and feedback, pharmacist as a reminder and education of staff
Knowledge Translation (KT) toolkit: KT toolkit consists of: use of pre-printed orders, use of pharmacist as project lead and human reminder for prescribing, audit and feedback, education for staff
|
AMI - Usual Care
n=105 Participants
Usual care as provided at the hospital
|
MGS - Knowledge Translation Toolkit
n=120 Participants
Knowledge Translation toolkit involves use of pre-printed orders, audit and feedback, pharmacist as reminder and education of staff
Knowledge Translation (KT) toolkit: KT toolkit consists of: use of pre-printed orders, use of pharmacist as project lead and human reminder for prescribing, audit and feedback, education for staff
|
MGS - Usual Care
n=120 Participants
Usual Care as provided at the hospital
|
HFS - Knowledge Translation Toolkit
n=105 Participants
Knowledge Translation Toolkit consists of pre-printed orders, audit and feedback, pharmacist as a reminder and education of staff
Knowledge Translation (KT) toolkit: KT toolkit consists of: use of pre-printed orders, use of pharmacist as project lead and human reminder for prescribing, audit and feedback, education for staff
|
HFS - Usual Care
n=135 Participants
Usual Care as provided at the hospital
|
|---|---|---|---|---|---|---|
|
Percentage of Patients Prescribed Appropriate VTE Prophylaxis
|
64 percentage of patients
Interval 0.89 to 3.36
|
62 percentage of patients
Interval 0.89 to
|
67 percentage of patients
|
54 percentage of patients
|
85 percentage of patients
|
76 percentage of patients
|
Adverse Events
AMI - Knowledge Translation Toolkit
AMI - Usual Care
MGS - Knowledge Translation Toolkit
MGS - Usual Care
HFS - Knowledge Translation Toolkit
HFS - Usual Care
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place